Wright Joseph 4
4 · MERIT MEDICAL SYSTEMS INC · Filed Mar 8, 2024
Insider Transaction Report
Form 4
Wright Joseph
Pres., Merit Technology Group
Transactions
- Exercise/Conversion
Common Stock, No Par Value
2024-03-07$28.20/sh+25,000$705,000→ 67,223 total - Exercise/Conversion
Non-qualified stock options (right to buy)
2024-03-07−25,000→ 0 totalExercise: $28.20From: 2018-04-14Exp: 2024-04-14→ Common Stock (25,000 underlying) - Sale
Common Stock, No Par Value
2024-03-07$75.68/sh−25,000$1,891,925→ 42,223 total
Holdings
- 9,681
Non-qualified stock options (right to buy)
Exercise: $56.25From: 2022-03-19Exp: 2028-03-19→ Common Stock (9,681 underlying) - 8,094
Non-qualified stock options (right to buy)
Exercise: $65.03From: 2023-02-28Exp: 2029-02-28→ Common Stock (8,094 underlying) - 25,000
Non-qualified stock options (right to buy)
Exercise: $44.80From: 2019-03-02Exp: 2025-03-02→ Common Stock (25,000 underlying) - 16,722
Non-qualified stock options (right to buy)
Exercise: $37.71From: 2021-02-26Exp: 2027-02-26→ Common Stock (16,722 underlying) - 13,576
Non-qualified stock options (right to buy)
Exercise: $70.58From: 2024-02-28Exp: 2030-02-28→ Common Stock (13,576 underlying) - 30,000
Non-qualified stock options (right to buy)
Exercise: $55.73From: 2020-03-01Exp: 2026-03-01→ Common Stock (30,000 underlying)
Footnotes (8)
- [F1]The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.234 to $76.220, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- [F2]Becomes exercisable in equal annual installments of 20% commencing on 04/14/2018.
- [F3]Becomes exercisable in equal annual installments of 20% commencing on 03/02/2019.
- [F4]Becomes exercisable in equal annual installments of 20% commencing on 03/01/2020.
- [F5]Becomes exercisable in equal annual installments of 25% commencing on 02/26/2021.
- [F6]Becomes exercisable in equal annual installments of 25% commencing on 03/19/2022.
- [F7]Becomes exercisable in equal annual installments of 25% commencing on 02/28/2023.
- [F8]Becomes exercisable in equal annual installments of 25% commencing on 02/28/2024.